{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:52:55Z","timestamp":1785268375617,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Connective tissue diseases (CTD) are characterised by the overproduction of multiple autoantibodies, especially antinuclear antibodies (ANA) of the IgG type. Meanwhile, also IgE autoantibodies have been described. The aim was therefore, to establish an ELISA for the demonstration of IgE autoantibodies to SSA\/Ro, SSB\/La, RNP proteins and dsDNA in sera from patients with systemic lupus erythematosus (SLE), Sjoegren\u2019s syndrome (SS), and mixed connective tissue disease (MCTD) to investigate their frequency and clinical relevance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples from 110 patients with SLE, 118 patients with SS, 41 patients with MCTD, and 73 controls were analysed by ELISA for IgE autoantibodies against dsDNA, SSA\/Ro52, and SSA\/Ro60, SSB\/La, and RNP proteins using recombinant antigens. Patients were assessed for different clinical manifestations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In SLE and SS, IgE anti-SSA\/Ro52-, -SSA\/Ro60- and -SSB\/La-antibodies showed a significantly higher reactivity than in controls. IgE anti-dsDNA-antibodies were present in 66% of SLE patients. In SLE, there was a correlation of IgE anti-dsDNA- and -anti-SSA\/Ro52-antibodies with disease activity and cutaneous manifestation. Neither IgE anti-SSA\/Ro- nor -anti-SSB\/La-antibodies were associated with distinct clinical manifestations in SS. Also, anti-RNP-antibodies were found to be of the IgE type (up to 90% in MCTD and 70% in SLE). In MCTD, IgE anti-Sm\/RNPB- and -anti-RNP68-antibodies correlated with pulmonary manifestations. IgE anti-dsDNA- but not the other IgE autoantibodies decreased under immunosuppressive therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IgE anti-SSA\/Ro-, -SSB\/La-, -RNP-, and -dsDNA antibodies show a high frequency and specificity for the prevailing CTD. We confirmed an association of anti-dsDNA and anti-SSA\/Ro52 antibodies with disease activity in SLE. In MCTD, there was an association of anti-Sm\/RNP B and -RNP68 antibodies with pulmonary disorder.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1483815","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:47:33Z","timestamp":1742456853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["IgE autoantibodies to nuclear antigens in patients with different connective tissue diseases: re-evaluation and novel findings"],"prefix":"10.3389","volume":"16","author":[{"given":"Kathrin","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christin","family":"Pecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101462","DOI":"10.1016\/j.berh.2019.101462","article-title":"Autoantibodies in connective tissue disease","volume":"34","author":"Mulhearn","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.3959","article-title":"American college of rheumatology\/European league against rheumatism classification criteria for primary sjogren\u2019s syndrome: A consensus and data-Driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0049-0172(80)90013-X","article-title":"Mixed connective tisssue disease: a clinicopathologic study of 20 cases","volume":"10","author":"Bennett","year":"1980","journal-title":"Semin Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197611182952101","article-title":"Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases","volume":"295","author":"Sharp","year":"1976","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.113.4.1346","article-title":"Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases","volume":"113","author":"Miyawaki","year":"1974","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000288293","article-title":"Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus","volume":"152","author":"Atta","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090424","article-title":"Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis","volume":"9","author":"Dema","year":"2014","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ni.3326","article-title":"Self-reactive IgE exacerbates interferon responses associated with autoimmunity","volume":"17","author":"Henault","year":"2016","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jaci.2020.12.622","article-title":"Basophils and IgE contribute to mixed connective tissue disease development","volume":"147","author":"Lamri","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/all.v78.12","article-title":"Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases","volume":"78","author":"Charles","year":"2023","journal-title":"Allergy."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004255","article-title":"Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse","volume":"10","author":"Himbert","year":"2024","journal-title":"RMD Open"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1978.tb02587.x","article-title":"The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus","author":"Permin","year":"1978","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0494-3","article-title":"Detection of serum IgE class anti-SSA antibodies in mothers with foetal loss","volume":"28","author":"Sekigawa","year":"2008","journal-title":"Rheumatol Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/s3pvx0","article-title":"Detection of IgE-autoantibodies to\u00a0nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance","volume":"42","author":"Kramer","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B21","article-title":"Preliminary diagnostic criteria for classification of mixed connective tissue disease","volume-title":"Mixed connective tissue disease and antinuclear antibodies","author":"Kasukawa","year":"1987"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606","article-title":"Derivation of\u00a0the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.Ipm.2014.03.002","article-title":"Why and how should we measure disease activity and damage in lupus","volume":"43","author":"Feld","year":"2014","journal-title":"Presse Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1033\/rheumatology\/kew319","article-title":"Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation","volume":"56","author":"Henes","year":"2017","journal-title":"Rheumatol (Oxford)."},{"key":"B25","volume-title":"Wahrscheinlichkeitsrechnung und Inferenzstatistik","author":"Nachtigall","year":"2004"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2159","article-title":"Basophils and the T helper 2 environment can promote the development of lupus nephritis","volume":"16","author":"Charles","year":"2010","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2273981","DOI":"10.1080\/0886022X.2023.2273981","article-title":"Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation","volume":"45","author":"Chen","year":"2023","journal-title":"Ren Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1191\/0961203306lu2323oa","article-title":"Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful","volume":"15","author":"Kallenberg","year":"2006","journal-title":"Lupus"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.05.001","article-title":"Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus: a meta-analysis","volume":"42","author":"Livingston","year":"2012","journal-title":"Semin Arthritis Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap9527","article-title":"A protective Langerhans cell-keratinocyte axis that is dysfunctional in\u00a0photosensitivity","volume":"10","author":"Shipman","year":"2018","journal-title":"Sci Transl Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318770016","article-title":"Photoprotection awareness and practices among patients with systemic lupus erythematosus and its association with disease activity and severity","volume":"27","author":"Abdul Kadir","year":"2018","journal-title":"Lupus."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140066","article-title":"Immunoglobulin E plays an immunoregulatory role in lupus","volume":"211","author":"Dema","year":"2014","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.03.015","article-title":"The high affinity IgE receptor: a signaling update","volume":"72","author":"Blank","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00689","article-title":"Immunoglobulin E-mediated autoimmunity","volume":"9","author":"Maurer","year":"2018","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2017.11.027","article-title":"IgE in lupus pathogenesis: Friends or foes","volume":"17","author":"Augusto","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/08916934.2017.1280670","article-title":"Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses","volume":"50","author":"Ettinger","year":"2017","journal-title":"Autoimmunity."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.015","article-title":"IgE\/fcepsilonRI-mediated antigen cross-presentation by dendritic cells enhances anti-tumor immune responses","volume":"10","author":"Platzer","year":"2015","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1483815\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:47:48Z","timestamp":1742456868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1483815\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2025.1483815"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1483815","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"article-number":"1483815"}}